Please provide your email address to receive an email when new articles are posted on . CLEVELAND — Every patient with systemic sclerosis should be screened for pulmonary arterial hypertension every ...
Scleroderma-related PAH remains a syndrome that is difficult to treat with currently available medical therapy, for reasons that are poorly understood. Although classified within the group 1 (PAH) of ...
Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
The Food and Drug Administration (FDA) has approved Ofev (nintedanib; Boehringer Ingelheim) capsules as the first FDA-approved treatment to slow the rate of decline in pulmonary function in patients ...
Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...
CHICAGO -- Rheumatologists need to be alert for pulmonary hypertension (PH) in their patients and have some understanding of its proper management, a researcher said here, because the condition is ...
Patients who underwent autologous stem cell transplantation (ASCT) for diffuse cutaneous systemic sclerosis (dcSSc), also known as scleroderma, did no better than others receiving conventional ...
Expert Rev Resp Med. 2009;3(2):187-196. Paul M. Hassoun, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD 21224, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results